Adaptimmune Therapeutics PLC ADAP Valuation Ratios and Share Stats

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics PLC (ADAP) Financials

Adaptimmune Therapeutics PLC (ADAP)

0.6616

0.025

(3.93%)

Closed November 24 4:00PM

Delayed by 15 minutes

0.66

-0.0016

(-0.24%)

After Hours: 5:34PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-28.528	-27.095	-32.115	-59.06	-41.124	-34.342	-41.444	-37.241
Return on Equity (%)	-37.337	-37.549	-39.621	-72.817	-55.97	-57.783	-114.965	-187.61
Return on Invested Capital (%)	-39.839	-41.9	-37.554	-75.864	-58.305	-58.316	-118.165	-204.198
Operating Margin (%)	-519.622	-211.252	-180.612	-12203.476	-3282.719	-2558.123	-600.262	-186.684
Net Profit Margin (%)	-484.568	-188.481	-153.861	-12225.045	-3286.812	-2570.987	-609.459	-188.9
Book Value Per Share	0.388	0.359	0.391	0.192	0.366	0.219	0.082	0.029
Earnings Per Share	-0.162	-0.127	-0.146	-0.217	-0.14	-0.169	-0.168	-0.084
Cash Per Share	0.374	0.15	0.109	0.08	0.061	0.16	0.109	0.106
Working Capital Per Share	0.373	0.277	0.329	0.137	0.387	0.376	0.193	0.099
Operating Profit Per Share	0.038	0.07	0.097	0.031	0.028	0.049	0.06	0.075
EBIT Per Share	-0.174	-0.143	-0.172	-0.217	-0.14	-0.168	-0.165	-0.083
EBITDA Per Share	-0.174	-0.143	-0.172	-0.217	-0.14	-0.168	-0.165	-0.083
Free Cash Flow Per Share	-0.133	-0.09	-0.151	-0.225	-0.145	-0.166	-0.144	-0.087

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	424.78M	562.12M	627.45M	631M	928.76M	937.55M	987.11M	1.36B

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	N/A	982.72M	987.11M	993.7M	1.35B	1.36B	1.36B	1.53B
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	3.489	N/A	N/A	N/A	-844.963
Net Profit Margin (%)	N/A	N/A	N/A	2.176	N/A	N/A	N/A	-854.227
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	706.36M
Price to Earnings Ratio	-6.43
Price to Sales Ratio	12.15
Price to Cash Ratio	5.08
Price to Book Ratio	18.53
Dividend Yield	-

Share Statistics

Shares Outstanding	1.11B
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Adaptimmune Therapeutics

Resources and Energy (PK)

S&P ASX 300 Shareholder ...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions